Pracinostat (SB939) is a novel HDAC inhibitor with improved in vivo properties compared to other HDAC inhibitors currently in Clinicalal trials, allowing oral dosing. Data demonstrate that Pracinostat is a potent and effective anti-tumor drug with potential as an oral therapy for a variety of human hematological and solid tumors.
Molecular Weight:
358.48
Purity:
99.67%
CAS Number:
[929016-96-6]
Formula:
C20H30N4O2
Target:
Apoptosis|||Antibacterial|||HDAC
T1890
* VAT and and shipping costs not included. Errors and price changes excepted
